IT8125582A0 - Composizione per il trattamento della psoriasi a base di un diidrossi-1,8 antrone-9 sostituito in posizione 10. - Google Patents

Composizione per il trattamento della psoriasi a base di un diidrossi-1,8 antrone-9 sostituito in posizione 10.

Info

Publication number
IT8125582A0
IT8125582A0 IT8125582A IT2558281A IT8125582A0 IT 8125582 A0 IT8125582 A0 IT 8125582A0 IT 8125582 A IT8125582 A IT 8125582A IT 2558281 A IT2558281 A IT 2558281A IT 8125582 A0 IT8125582 A0 IT 8125582A0
Authority
IT
Italy
Prior art keywords
anthron
dihydroxy
substituted
treatment
composition
Prior art date
Application number
IT8125582A
Other languages
English (en)
Other versions
IT1142097B (it
Inventor
Braham Shroot
Jean Maignan
Gerard Lang
Original Assignee
Cird
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cird filed Critical Cird
Publication of IT8125582A0 publication Critical patent/IT8125582A0/it
Application granted granted Critical
Publication of IT1142097B publication Critical patent/IT1142097B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
IT25582/81A 1980-12-15 1981-12-14 Composizione per il trattamento della psoriasi a base di un diidrossi-1,8 antrone-9 sostituito in posizione 10 IT1142097B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8026550A FR2495934A1 (fr) 1980-12-15 1980-12-15 Composition pour le traitement du psoriasis a base d'une dihydroxy-1,8 anthrone-9 substituee en position 10

Publications (2)

Publication Number Publication Date
IT8125582A0 true IT8125582A0 (it) 1981-12-14
IT1142097B IT1142097B (it) 1986-10-08

Family

ID=9249080

Family Applications (1)

Application Number Title Priority Date Filing Date
IT25582/81A IT1142097B (it) 1980-12-15 1981-12-14 Composizione per il trattamento della psoriasi a base di un diidrossi-1,8 antrone-9 sostituito in posizione 10

Country Status (11)

Country Link
US (1) US4405615A (it)
JP (1) JPS57163311A (it)
BE (1) BE891467A (it)
CA (1) CA1186228A (it)
CH (1) CH649708A5 (it)
DE (1) DE3149528C2 (it)
FR (1) FR2495934A1 (it)
GB (1) GB2091999B (it)
IT (1) IT1142097B (it)
NL (1) NL8105618A (it)
SE (1) SE453961B (it)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2565966B1 (fr) * 1984-06-13 1986-08-29 Cird Aryl-10 dihydroxy-1,8 anthrones et leurs esters, leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique
FR2567402B1 (fr) * 1984-07-12 1988-07-01 Cird Nouvelles compositions pharmaceutiques et cosmetiques contenant comme ingredient actif la dihydroxy-1,8 phenyl-10 anthrone-9, et procede de preparation de l'ingredient actif
WO1989003822A1 (en) * 1987-10-22 1989-05-05 The Victoria University Of Manchester New compounds of the anthraquinone series
EP0586479A1 (en) * 1991-05-29 1994-03-16 Pfizer Inc. Dihydroxyindanone tyrosine kinase inhibitors
DE4231636A1 (de) * 1992-09-22 1994-03-24 Beiersdorf Ag Neue in 10-Stellung substituierte Anthron- und Anthracen-Derivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende pharmazeutische oder kosmetische Mittel und deren Verwendung
ATE229817T1 (de) * 1996-10-24 2003-01-15 Alza Corp Penetrationsfördernde substanzen für die transdermale verabreichung von wirkstoffen, vorrichtungen und verfahren zur herstellung
JP2007513173A (ja) * 2003-12-03 2007-05-24 スミスクライン・ビーチャム・コーポレイション ロシグリタゾンを用いる乾癬の治療

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2256663A1 (de) * 1972-11-18 1974-05-22 Basf Ag Verfahren zur herstellung von chloranthrachinon-2,3-dicarbonsaeureanhydriden
US3835167A (en) * 1972-12-18 1974-09-10 Syntex Inc Anthrone carboxylic acids and derivatives

Also Published As

Publication number Publication date
CH649708A5 (fr) 1985-06-14
DE3149528A1 (de) 1982-08-19
FR2495934B1 (it) 1983-06-17
CA1186228A (fr) 1985-04-30
FR2495934A1 (fr) 1982-06-18
BE891467A (fr) 1982-06-14
SE8107468L (sv) 1982-06-16
NL8105618A (nl) 1982-07-01
JPS57163311A (en) 1982-10-07
DE3149528C2 (de) 1985-10-31
GB2091999B (en) 1984-08-15
GB2091999A (en) 1982-08-11
US4405615A (en) 1983-09-20
SE453961B (sv) 1988-03-21
IT1142097B (it) 1986-10-08

Similar Documents

Publication Publication Date Title
IT7924390A0 (it) Vite trapanante d'acciaio inossidabile procedimento per fabbricarla.
DK554084D0 (da) 26,26,26,27,27,27-hexafluor-1alfa,25-dihydroxycholesterol
DK278379A (da) Mercaptosubstituerede 2,3,4,5-tetrahydro-1h-3-benzazeptiner
FR2477145B1 (fr) 25-hydroxy-26, 26, 26, 27, 27, 27-hexafluorocholecalciferol
DE3381536D1 (de) Tastatur.
FI812270L (fi) Antiinflammatoriska 4,5-diaryl-alfa-polyfluoralkyl-1h-imidazol-2-metanaminer
IT8026684A0 (it) Dispositivo d'illuminazione di tastiere.
IT8125582A0 (it) Composizione per il trattamento della psoriasi a base di un diidrossi-1,8 antrone-9 sostituito in posizione 10.
FI811191L (fi) Antiinflammatoriska 4,5-diaryl-alfa-(polyfluoralkyl)-1h-pyrrol-2-metanaminer
DK155594C (da) 3,3-dimethyl-1-phenoxybutan-2-oler
NO168639C (no) Nye n-klorsulfonyl-2-oksindal-1-karboksamider.
DE3675432D1 (de) 1,3-dioxanaether.
FI853421L (fi) 7-oxo-4-tia-1-azabicyklo/3,2,0/ hept-2-enderivat.
IT1098015B (it) Nuovi 4,5,6,7,-tetraidroimidazo-aperta par.quadrata 4,5-c chiusa par.quadrata-piridin-derivati
DE3576334D1 (de) 1,2,3,3a,8,8a-hexahydro-indeno-(1,2-c)pyrrde.
NZ185214A (en) 4-(2)-styrylhexahydro-3ars, 4rs, 7ars-indolin-4-ols
DE3175752D1 (de) 1,3-dihalopropan-2-ols
FI810242L (fi) 1,3-diformyloxi-2-brom-nitropropan
FI854026L (fi) 2-fenylpyrano/2,3-b/pyridiner.
IT8024315A0 (it) Base rotante per apparecchi di controllo dell'avantreno.
FI852405L (fi) Substituerade 3,4-diamino-1,2,5 -tiadiazoler med antagoniserande inverkan pao histaminets h2-receptorer.
IT1189011B (it) 1,4;3,6-dinanidro-2,5-diazido-2,5-dideossi-esitoli
ATE10092T1 (de) Entzuendungshemmende 4,5-diaryl-alphapolyfluoralkyl-1h-imidazol-2-methanamine.
NO163616C (no) Nytt 1,4-dihalogenbutan-2,3-dion.
IT8033323V0 (it) Risparmio energetico n.1